tirzepatide and not losing weight Tirzepatide: A Breakthrough Approach to Safely Tirzepatide for Medical Weight Loss

Bottom line: choose Allara if you have PCOS or a hormonal condition and want a GLP-1 program built around it

Meta-analyses have shown that the amount of weight regained after stopping treatment is typically proportional to the initial weight loss, and lifestyle interventions become increasingly difficult to maintain once the medication is discontinued (Berg et al., 2025)

Introduced by Novo Nordisk in 2026, oral semaglutide was the first oral GLP-1 treatment approved particularly for weight loss

Some preliminary studies suggest that collagen supplementation may support hair thickness, though the research is still early

Its once-weekly dosing and potential cardiovascular benefits make tirzepatide an attractive option for treating these conditions (Fig